Passage Bio (PASG) 10-K2023 FY Annual report

Filed: 4 Mar 24, 7:15am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: accreted, Africa, alkaline, ALT, ameliorate, ANOVA, antagonist, ascending, AST, Athena, Australia, autofluorescence, bar, bilirubin, biometric, biotech, Borthwick, built, Cale, career, Chip, Chou, configuring, Connecticut, counterparty, County, cybersecurity, cytoplasm, cytoplasmic, Dashed, degenerative, dendritic, Derrell, dialogue, digit, discretionary, disqualifying, diversified, divestiture, Division, Dolan, DPF, duly, East, Edgar, email, Erroneously, exacerbate, FDIC, Florida, flow, Forman, GC, GGT, Gowen, green, hardening, hepatotoxicity, hereto, hybrid, hyperphosphorylated, imaging, importantly, Inline, insoluble, intelligence, intrusion, ITFFB, Kathleen, King, Kiran, Kirin, Kyowa, lab, lessor, LFT, Linkbase, LP, Maxine, mental, methylprednisolone, mg, microglial, mind, missing, mm, Monika, Novo, nuclear, obstacle, occupancy, omitted, overseen, page, paused, phosphatase, plaintiff, Plaza, pleiotropic, polymorphism, Porter, postulate, prednisone, promptly, quickly, ratifying, regiment, regular, regularly, resubstitution, ribonuclear, SAE, salary, Schema, SEM, signature, Silicon, Simona, SNP, Sondhi, South, splicing, stead, steroid, streamlined, sublease, subleased, Sublessee, substance, subtenant, Supplementary, SVB, TAR, tau, Taxonomy, thereunto, therewith, thing, threat, tied, Toernsen, top, trafficking, true, Tukey, turmoil, ULN, unaltered, undersigned, uninterrupted, Utah, Valley, variance, version, VesperBio, vigorously, virtue, vulnerability, Wage, week, William, withdrew, XBRL, zebrafish

Removed: Aid, aspiration, atrophy, Bayley, biology, Bioscience, cancer, characterization, chose, clinic, close, commissioning, contemplated, continuum, craniocervical, cutting, deducting, devoted, diffuse, direction, displayed, distinguish, dysplasia, edge, EEG, engineering, enlarged, enlargement, entirety, equipping, expedited, expensing, exploit, extracellular, familial, feeding, financed, forefront, founded, fulfil, gait, GMP, greatest, greatly, groundbreaking, grow, histologic, histological, hypotonia, IIa, improving, infant, interval, intrinsic, investigative, Invitae, involvement, IRS, junction, juvenile, live, longitudinal, lung, Lysogene, med, medicinal, MHRA, molecularly, MRI, muscle, nondeductible, observation, ODC, organizing, pandemic, Paragon, pathogenic, phenotypic, pioneering, plc, pneumonia, practical, PREA, progressing, promise, qualification, rational, reducing, regression, replacement, repurchase, restoring, retrospective, reversing, rigidity, RPDD, score, skeletal, subpopulation, supportive, survive, synthesized, tenant, tone, transitioning, translational, underserved, underwriting, uptake, utilizing, ventricular, verify, wildtype

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

PASG similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Kathleen Borthwick, Chief Financial Officer of Passage Bio, Inc. (the “Company”), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

1. the Annual Report on Form 10-K of the Company for the fiscal year ended December 31, 2023 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Dated: March 4, 2024	/s/ Kathleen Borthwick
	Kathleen Borthwick
	Chief Financial Officer
	(Principal Financial Officer and Principal Accounting Officer)